أعرض في EDS

A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Ivarmacitinib (SHR0302) in Adult Patients with Moderate to Severe Alopecia Areata

التفاصيل البيبلوغرافية
العنوان: A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Ivarmacitinib (SHR0302) in Adult Patients with Moderate to Severe Alopecia Areata
المؤلفون: Cheng Zhou, Xiumin Yang, Bin Yang, Guofu Yan, Xiuqin Dong, Yangfeng Ding, Weixin Fan, Linfeng Li, Dingquan Yang, Hong Fang, Chao Ji, Hao Cheng, Shoumin Zhang, Aik Han Goh, Rongjun Liu, Xiaoyu Gu, Zaili Weng, Peter Foley, Rodney Sinclair, Jianzhong Zhang
المصدر: Journal of the American Academy of Dermatology.
بيانات النشر: Elsevier BV, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Dermatology
تدمد: 0190-9622
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3790e5b4ee8c7b807570c7d53de40702
https://doi.org/10.1016/j.jaad.2023.02.063
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........3790e5b4ee8c7b807570c7d53de40702
قاعدة البيانات: OpenAIRE
الوصف
تدمد:01909622